{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Formulation of human antibodies for treating TNF-alpha associated disorders", "item": "https://www.patentleaderboard.com/patent/9220781"}]}

Home › Formulation of human antibodies for treating TNF-alpha associated disorders

Formulation of human antibodies for treating TNF-alpha associated disorders

US Patent 9220781 · Granted Dec 29, 2015

Estimated economic value: $639,385,000 ⓘ

Assignee

AbbVie

Inventors

Hans-Juergen Krause (33 patents)
Lisa Baust (22 patents)
Michael Dickes (23 patents)

View full patent text on Google Patents →